Company Filing History:
Years Active: 2021
Title: Geetha Hanna Mylvaganam: Innovator in Drug Responsive Domains
Introduction
Geetha Hanna Mylvaganam is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of drug responsive domains. Her innovative work focuses on enhancing the stability of therapeutic proteins, which can lead to improved treatment options for various diseases.
Latest Patents
Geetha holds a patent for "CA2 compositions and methods for tunable regulation." This patent describes drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads. The compositions and methods outlined in her patent have the potential to revolutionize the way therapeutic proteins are utilized in medical treatments.
Career Highlights
Geetha is currently employed at Obsidian Therapeutics, Inc., where she continues to push the boundaries of innovation in biotechnology. Her work at the company emphasizes the importance of developing advanced therapeutic solutions that can adapt to the needs of patients.
Collaborations
Throughout her career, Geetha has collaborated with talented individuals such as Kutlu Goksu Elpek and Dhruv Kam Sethi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of scientific knowledge.
Conclusion
Geetha Hanna Mylvaganam is a trailblazer in the field of biotechnology, with her innovative patent and contributions to drug responsive domains. Her work at Obsidian Therapeutics, Inc. and collaborations with esteemed colleagues highlight her commitment to advancing medical science.